Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J Pishvaian

Showing results (1-10 of 96) with videos related to

Pageof 10
Sort By:
Seminars in Radiation Oncology|September 11, 2025
Driving Precision Medicine in Pancreatic Cancer With Molecular GeneticsMaria Farooq, Michael J Pishvaian
Drug Design, Development and Therapy|July 31, 2014
Profile and potential of ixabepilone in the treatment of pancreatic cancerBrandon G Smaglo, Michael J Pishvaian
Cancer Biomarkers : Section a of Disease Markers|October 6, 2007
Biomarkers of WNT signalingMichael J Pishvaian, Stephen W Byers
Current Drug Targets|January 7, 2014
Targeting the BRCA1/2 tumor suppressorsEliot M Rosen, Michael J Pishvaian
Oncology (Williston Park, N.Y.)|March 17, 2017
Therapeutic Implications of Molecular Subtyping for Pancreatic CancerMichael J Pishvaian, Jonathan R Brody
Cancer Journal (Sudbury, Mass.)|November 29, 2012
Postresection chemotherapy for pancreatic cancerBrandon G Smaglo, Michael J Pishvaian
The American Journal of Pathology|March 10, 2015
Cyclin-dependent kinase inhibitors and the treatment of gastrointestinal cancersSameh Mikhail, Christopher Albanese, Michael J Pishvaian
Gastrointestinal Cancer Research : GCR|April 6, 2011
Molecularly targeted therapy for metastatic colon cancer: proven treatments and promising new agentsMajed El Zouhairi, Aline Charabaty, Michael J Pishvaian
Medical Oncology (Northwood, London, England)|April 30, 2015
Retrievable inferior vena cava filters in patients with cancer are safe but are they beneficial?Sameh Mikhail, Lindsay Hannan, Michael J Pishvaian, et al.
Gastrointestinal Cancer Research : GCR|June 16, 2011
Current management of inflammatory bowel disease and colorectal cancerMark C Mattar, Denver Lough, Michael J Pishvaian, et al.
Pageof 10

Showing results (1-10 of 96) with videos related to

Sort By:
Pageof 10
Seminars in Radiation Oncology|September 11, 2025
Driving Precision Medicine in Pancreatic Cancer With Molecular GeneticsMaria Farooq, Michael J Pishvaian
Drug Design, Development and Therapy|July 31, 2014
Profile and potential of ixabepilone in the treatment of pancreatic cancerBrandon G Smaglo, Michael J Pishvaian
Cancer Biomarkers : Section a of Disease Markers|October 6, 2007
Biomarkers of WNT signalingMichael J Pishvaian, Stephen W Byers
Current Drug Targets|January 7, 2014
Targeting the BRCA1/2 tumor suppressorsEliot M Rosen, Michael J Pishvaian
Oncology (Williston Park, N.Y.)|March 17, 2017
Therapeutic Implications of Molecular Subtyping for Pancreatic CancerMichael J Pishvaian, Jonathan R Brody
Cancer Journal (Sudbury, Mass.)|November 29, 2012
Postresection chemotherapy for pancreatic cancerBrandon G Smaglo, Michael J Pishvaian
The American Journal of Pathology|March 10, 2015
Cyclin-dependent kinase inhibitors and the treatment of gastrointestinal cancersSameh Mikhail, Christopher Albanese, Michael J Pishvaian
Gastrointestinal Cancer Research : GCR|April 6, 2011
Molecularly targeted therapy for metastatic colon cancer: proven treatments and promising new agentsMajed El Zouhairi, Aline Charabaty, Michael J Pishvaian
Medical Oncology (Northwood, London, England)|April 30, 2015
Retrievable inferior vena cava filters in patients with cancer are safe but are they beneficial?Sameh Mikhail, Lindsay Hannan, Michael J Pishvaian, et al.
Gastrointestinal Cancer Research : GCR|June 16, 2011
Current management of inflammatory bowel disease and colorectal cancerMark C Mattar, Denver Lough, Michael J Pishvaian, et al.
Pageof 10